Accelerating real-world evidence with agentic AI
Real-world evidence (RWE) studies often stall on the same friction points: defining the most...
Menopause at a turning point: RWD matters more than ever
A recent CNBC article used HealthVerity real-world data (RWD) to highlight a shortage of estrogen patches that is visible in RWD as demand for menopause support skyrockets. Menopause affects millions of women, yet it has long remained one of the...
Veterans Day at HealthVerity: Two paths from service to impact
Veterans Day invites us to look beyond branch and rank to the people and stories behind the...
Alzheimer’s disease in the real world: Where evidence matters most
Alzheimer’s disease burden and the current therapy pipeline Alzheimer’s disease remains the leading...
Insights from IMPACCT 2025: advancing real-world evidence
Identifying the gaps in today’s real-world data The 2025 IMPACCT Real-World Evidence Summit brought...
Trusted by the NSF: How HealthVerity set the standard for secure data linkage
When two federal agencies, the National Center for Science and Engineering Statistics (NCSES) and...
Understanding the breast cancer patient journey in 2025
October is Breast Cancer Awareness Month. While pink ribbons and fundraising campaigns help bring...
How AI is changing epidemiology and real-world evidence
AI changed how we discover medicines. What's next? In just a few years, artificial intelligence...
How taXonomy Pathways builds comprehensive patient journeys
In a recent webinar, the HealthVerity team including Alexa Woodward, Ph.D., Director of Strategic...
RWE with transparent AI: Insights from the HealthVerity eXOs webinar
When we introduced HealthVerity eXOs, an agentic AI platform powered by Medeloop, in our recent...
Real-world data for heart failure: Closing evidence gaps across the patient journey
The evolution of heart failure treatment and research Heart failure remains one of the most...